side effect from semaglutide effects for diabetes and obesity treatment Medinaz - 🟣 Ozempic (Semaglutide)

This review summarises recent advances in the understanding of diabetic gastroparesis, with an emphasis on the current therapies that influence GE, and the bidirectional relationship between glycaemic control and GE.

Here we hypothesize that manipulating glucagon-like peptide-1 receptor (GLP-1R) activity selectively in the LH can profoundly affect food reward behavior, ultimately leading to obesity

GLP-1 receptor agonists are prescribed off-label for weight loss in non-diabetic adults with obesity or overweight status plus weight-related comorbidities

In this review we summarize the results of recent cardiovascular outcome trials and discuss the potential clinical advantage of SGLT2 inhibitors and GLP-1 receptor agonists

The Bristol Stool Chart is often used by doctors to assess whether your poop is healthy or youre having health issues like constipation, diarrhea, or an underlying condition.

Here we investigate the effects of liraglutide, a GLP-1 receptor agonist, in two well characterised transgenic mouse models of ALS (SOD1G93A and TDP-43Q331K) to determine if liraglutide could be a potential treatment in ALS patients